• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明矾佐剂肽与碳水化合物结合疫苗候选物在非人灵长类动物模型中抗A组咽部感染的疗效

Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Pharyngeal Infection in a Non-Human Primate Model.

作者信息

Rivera-Hernandez Tania, Carnathan Diane G, Richter Johanna, Marchant Patrick, Cork Amanda J, Elangovan Gayathiri, Henningham Anna, Cole Jason N, Choudhury Biswa, Moyle Peter M, Toth Istvan, Batzloff Michael R, Good Michael F, Agarwal Paresh, Kapoor Neeraj, Nizet Victor, Silvestri Guido, Walker Mark J

机构信息

Consejo Nacional de Humanidades Ciencia y Tecnología, Unidad de Investigación Médica en Inmunoquímica, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.

School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD 4072, Australia.

出版信息

Vaccines (Basel). 2024 Apr 4;12(4):382. doi: 10.3390/vaccines12040382.

DOI:10.3390/vaccines12040382
PMID:38675764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11054769/
Abstract

Vaccine development against group A (GAS) has gained traction in the last decade, fuelled by recognition of the significant worldwide burden of the disease. Several vaccine candidates are currently being evaluated in preclinical and early clinical studies. Here, we investigate two conjugate vaccine candidates that have shown promise in mouse models of infection. Two antigens, the J8 peptide from the conserved C-terminal end of the M protein, and the group A carbohydrate lacking -acetylglucosamine side chain (ΔGAC) were each conjugated to arginine deiminase (ADI), an anchorless surface protein from GAS. Both conjugate vaccine candidates combined with alum adjuvant were tested in a non-human primate (NHP) model of pharyngeal infection. High antibody titres were detected against J8 and ADI antigens, while high background antibody titres in NHP sera hindered accurate quantification of ΔGAC-specific antibodies. The severity of pharyngitis and tonsillitis signs, as well as the level of GAS colonisation, showed no significant differences in NHPs immunised with either conjugate vaccine candidate compared to NHPs in the negative control group.

摘要

在过去十年中,鉴于认识到A群链球菌(GAS)在全球造成的重大疾病负担,针对该病菌的疫苗研发工作受到了广泛关注。目前,有几种候选疫苗正在进行临床前和早期临床研究评估。在此,我们研究了两种在感染小鼠模型中显示出前景的结合疫苗候选物。两种抗原,即来自M蛋白保守C末端的J8肽和缺乏N-乙酰葡糖胺侧链的A群碳水化合物(ΔGAC),分别与精氨酸脱氨酶(ADI)偶联,ADI是一种来自GAS的无锚定表面蛋白。两种结合疫苗候选物与明矾佐剂联合,在咽部感染的非人类灵长类动物(NHP)模型中进行了测试。检测到针对J8和ADI抗原的高抗体滴度,而NHP血清中的高背景抗体滴度阻碍了对ΔGAC特异性抗体的准确定量。与阴性对照组的NHP相比,用任何一种结合疫苗候选物免疫的NHP中,咽炎和扁桃体炎体征的严重程度以及GAS定植水平均无显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/11054769/4321fe3c5d48/vaccines-12-00382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/11054769/012efc46402a/vaccines-12-00382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/11054769/aa879f02bcca/vaccines-12-00382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/11054769/4321fe3c5d48/vaccines-12-00382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/11054769/012efc46402a/vaccines-12-00382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/11054769/aa879f02bcca/vaccines-12-00382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d89/11054769/4321fe3c5d48/vaccines-12-00382-g003.jpg

相似文献

1
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Pharyngeal Infection in a Non-Human Primate Model.明矾佐剂肽与碳水化合物结合疫苗候选物在非人灵长类动物模型中抗A组咽部感染的疗效
Vaccines (Basel). 2024 Apr 4;12(4):382. doi: 10.3390/vaccines12040382.
2
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models.A群链球菌候选疫苗和全长M蛋白在皮肤和侵袭性疾病模型中的不同疗效
mBio. 2016 Jun 14;7(3):e00618-16. doi: 10.1128/mBio.00618-16.
3
An Experimental Group A Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model.一种实验组 A 疫苗,可减少非人类灵长类动物模型中的咽炎和扁桃体炎。
mBio. 2019 Apr 30;10(2):e00693-19. doi: 10.1128/mBio.00693-19.
4
Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197.与CRM197偶联的A组链球菌J8肽候选疫苗在小鼠和非人类灵长类动物中的免疫原性。
Hum Vaccin Immunother. 2013 Mar;9(3):488-96. doi: 10.4161/hv.23224. Epub 2012 Dec 18.
5
Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein-Fusion Combination Vaccine.酶介导的、定点的方法将 Toll 样受体 2 激动剂偶联到蛋白抗原上的开发:朝着广泛保护性的、四组分的 A 组溶血性链球菌自佐剂化脂蛋白融合联合疫苗发展。
ACS Infect Dis. 2020 Jul 10;6(7):1770-1782. doi: 10.1021/acsinfecdis.0c00047. Epub 2020 Jun 1.
6
Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope.通过鼻内免疫含有保守M蛋白B细胞表位且缺乏T细胞自身表位的肽疫苗来保护小鼠免受A组链球菌感染。
Vaccine. 2002 Jun 21;20(21-22):2816-25. doi: 10.1016/s0264-410x(02)00205-0.
7
M-protein based vaccine induces immunogenicity and protection from when delivered on a high-density microarray patch (HD-MAP).基于M蛋白的疫苗通过高密度微阵列贴片(HD-MAP)递送时可诱导免疫原性并提供保护。
NPJ Vaccines. 2020 Aug 7;5(1):74. doi: 10.1038/s41541-020-00222-2. eCollection 2020.
8
Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection.用J8-白喉类毒素免疫预防A组链球菌:J8特异性抗体和白喉类毒素特异性抗体对保护作用的贡献。
J Infect Dis. 2003 May 15;187(10):1598-608. doi: 10.1086/374800. Epub 2003 Apr 30.
9
Investigation of group A Streptococcus immune responses in an endemic setting, with a particular focus on J8.A 组链球菌免疫应答的流行环境调查,特别关注 J8 亚型。
Vaccine. 2018 Nov 29;36(50):7618-7624. doi: 10.1016/j.vaccine.2018.10.091. Epub 2018 Nov 3.
10
A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteers.一项在健康志愿者中进行的基于肽的 A 组链球菌疫苗的 1 期随机对照试验。
Trials. 2024 Nov 19;25(1):781. doi: 10.1186/s13063-024-08634-4.

本文引用的文献

1
Update on the development of Group A Streptococcus vaccines.A组链球菌疫苗的研发进展
NPJ Vaccines. 2023 Sep 14;8(1):135. doi: 10.1038/s41541-023-00730-x.
2
The Streptococcus pyogenes vaccine landscape.化脓性链球菌疫苗的情况。
NPJ Vaccines. 2023 Feb 14;8(1):16. doi: 10.1038/s41541-023-00609-x.
3
GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A .GMMA作为一种针对A群糖缀合物疫苗的替代载体
Vaccines (Basel). 2022 Jun 28;10(7):1034. doi: 10.3390/vaccines10071034.
4
Non-Native Amino Acid Click Chemistry-Based Technology for Site-Specific Polysaccharide Conjugation to a Bacterial Protein Serving as Both Carrier and Vaccine Antigen.基于非天然氨基酸点击化学的技术,用于将多糖位点特异性缀合至作为载体和疫苗抗原的细菌蛋白。
ACS Omega. 2022 Jul 11;7(28):24111-24120. doi: 10.1021/acsomega.1c07360. eCollection 2022 Jul 19.
5
The global burden of sore throat and group A pharyngitis: A systematic review and meta-analysis.咽喉痛和A组咽炎的全球负担:一项系统评价和荟萃分析。
EClinicalMedicine. 2022 May 20;48:101458. doi: 10.1016/j.eclinm.2022.101458. eCollection 2022 Jun.
6
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study.化脓性链球菌咽炎的受控人体感染模型(CHIVAS-M75):一项观察性剂量探索研究。
Lancet Microbe. 2021 Jul;2(7):e291-e299. doi: 10.1016/S2666-5247(20)30240-8. Epub 2021 Apr 15.
7
StreptInCor, a Group A Streptococcal Adsorbed Vaccine: Evaluation of Repeated Intramuscular Dose Toxicity Testing in Rats.A群链球菌吸附疫苗StreptInCor:大鼠重复肌内注射剂量毒性试验评估
Front Cardiovasc Med. 2021 May 11;8:643317. doi: 10.3389/fcvm.2021.643317. eCollection 2021.
8
Update on group A streptococcal vaccine development.A 组链球菌疫苗开发的最新进展。
Curr Opin Infect Dis. 2020 Jun;33(3):244-250. doi: 10.1097/QCO.0000000000000644.
9
Vaccine-Induced Th1-Type Response Protects against Invasive Group A Infection in the Absence of Opsonizing Antibodies.疫苗诱导的 Th1 型反应可在没有调理抗体的情况下预防侵袭性 A 组感染。
mBio. 2020 Mar 10;11(2):e00122-20. doi: 10.1128/mBio.00122-20.
10
Group A Cell Wall Oligosaccharide-Streptococcal C5a Peptidase Conjugates as Effective Antibacterial Vaccines.A组 细胞壁寡糖-链球菌C5a肽酶缀合物作为有效的抗菌疫苗
ACS Infect Dis. 2020 Feb 14;6(2):281-290. doi: 10.1021/acsinfecdis.9b00347. Epub 2020 Jan 7.